BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 15790460)

  • 1. Vascular endothelial growth factor (VEGF) up-regulates epidermal growth factor receptor (EGF-R) in cervical cancer in vitro: this action is mediated through HPV-E6 in HPV-positive cancers.
    Mathur RS; Mathur SP
    Gynecol Oncol; 2005 Apr; 97(1):206-13. PubMed ID: 15790460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of vascular endothelial growth factor-C by nicotine in cervical cancer cell lines.
    Lane D; Gray EA; Mathur RS; Mathur SP
    Am J Reprod Immunol; 2005 Mar; 53(3):153-8. PubMed ID: 15727570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner.
    López-Ocejo O; Viloria-Petit A; Bequet-Romero M; Mukhopadhyay D; Rak J; Kerbel RS
    Oncogene; 2000 Sep; 19(40):4611-20. PubMed ID: 11030150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro downregulation of growth factors by insulin-like growth factor binding protein-3 in cervical cancer.
    Mathur RS; Mathur SP
    Gynecol Oncol; 2003 Nov; 91(2):410-5. PubMed ID: 14599874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor suppresses insulin-like growth factor binding protein 3 levels in human papillomavirus type 16-immortalized cervical epithelial cells and thereby potentiates the effects of insulin-like growth factor 1.
    Hembree JR; Agarwal C; Eckert RL
    Cancer Res; 1994 Jun; 54(12):3160-6. PubMed ID: 7515765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro antigene therapy targeting HPV-16 E6 and E7 in cervical carcinoma.
    Madrigal M; Janicek MF; Sevin BU; Perras J; Estape R; Peñalver M; Averette HE
    Gynecol Oncol; 1997 Jan; 64(1):18-25. PubMed ID: 8995542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of IGF-I and insulin receptor isoforms in HPV positive and negative human cervical cancer cell lines.
    Serrano ML; Sánchez-Gómez M; Bravo MM; Yakar S; LeRoith D
    Horm Metab Res; 2008 Oct; 40(10):661-7. PubMed ID: 18711691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity to Fas-mediated apoptosis in high-risk HPV-positive human cervical cancer cells: relationship with Fas, caspase-8, and Bid.
    Hougardy BM; van der Zee AG; van den Heuvel FA; Timmer T; de Vries EG; de Jong S
    Gynecol Oncol; 2005 May; 97(2):353-64. PubMed ID: 15863130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of anti-HPV16 E6-ribozyme on invasiveness of cervical carcinoma cell line CaSKi and vascular endothelial growth factor expression].
    Liu K; Wang LL; Zheng YF; Zhang JR
    Di Yi Jun Yi Da Xue Xue Bao; 2004 May; 24(5):529-32. PubMed ID: 15151824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-6 in cervical cancer: the relationship with vascular endothelial growth factor.
    Wei LH; Kuo ML; Chen CA; Cheng WF; Cheng SP; Hsieh FJ; Hsieh CY
    Gynecol Oncol; 2001 Jul; 82(1):49-56. PubMed ID: 11426961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of green tea extract on expression of human papillomavirus type 16 oncoproteins-induced hypoxia-inducible factor-1alpha and vascular endothelial growth factor in human cervical carcinoma cells].
    Tang XD; Zhou X; Zhang QZ; Le AD; Zhou KY
    Zhonghua Yi Xue Za Zhi; 2008 Nov; 88(40):2872-7. PubMed ID: 19080502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant adenovirus-p53 gene transfer and cell-specific growth suppression of human cervical cancer cells in vitro and in vivo.
    Ahn WS; Bae SM; Lee KH; Lee JM; Namkoong SE; Chun HJ; Kim CK; Kim YW
    Gynecol Oncol; 2004 Feb; 92(2):611-21. PubMed ID: 14766255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship between nitric oxide in cervical microenvironment and different HPV types and effect on cervical cancer cells].
    Wei XM; Wang Q; Gao SJ; Sui L
    Zhonghua Fu Chan Ke Za Zhi; 2011 Apr; 46(4):260-5. PubMed ID: 21609578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of vascular endothelial growth factor expression by insulin-like growth factor-II in human keratinocytes, differential involvement of mitogen-activated protein kinases and feedback inhibition of protein kinase C.
    Kim HJ; Kim TY
    Br J Dermatol; 2005 Mar; 152(3):418-25. PubMed ID: 15787809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor action of curcumin in human papillomavirus associated cells involves downregulation of viral oncogenes, prevention of NFkB and AP-1 translocation, and modulation of apoptosis.
    Divya CS; Pillai MR
    Mol Carcinog; 2006 May; 45(5):320-32. PubMed ID: 16526022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus 16 immortalization of normal human ectocervical epithelial cells alters retinoic acid regulation of cell growth and epidermal growth factor receptor expression.
    Sizemore N; Rorke EA
    Cancer Res; 1993 Oct; 53(19):4511-7. PubMed ID: 8402622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HPV-16-related proteins as the serologic markers in cervical neoplasia.
    Park JS; Park DC; Kim CJ; Ahn HK; Um SJ; Park SN; Kim SJ; Namkoong SE
    Gynecol Oncol; 1998 Apr; 69(1):47-55. PubMed ID: 9570998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted disruption of the epidermal growth factor receptor inhibits development of papillomas and carcinomas from human papillomavirus-immortalized keratinocytes.
    Woodworth CD; Gaiotti D; Michael E; Hansen L; Nees M
    Cancer Res; 2000 Aug; 60(16):4397-402. PubMed ID: 10969784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of vascular endothelial growth factor in squamous cell carcinomas of the tonsil in relation to human papillomavirus status and epidermal growth factor receptor.
    Fei J; Hong A; Dobbins TA; Jones D; Lee CS; Loo C; Al-Ghamdi M; Harnett GB; Clark J; O'Brien CJ; Rose B
    Ann Surg Oncol; 2009 Oct; 16(10):2908-17. PubMed ID: 19603236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of proliferation of PC-3 human prostate cancer by antagonists of growth hormone-releasing hormone: lack of correlation with the levels of serum IGF-I and expression of tumoral IGF-II and vascular endothelial growth factor.
    Plonowski A; Schally AV; Letsch M; Krupa M; Hebert F; Busto R; Groot K; Varga JL
    Prostate; 2002 Aug; 52(3):173-82. PubMed ID: 12111694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.